CLPT
HEALTHCAREClearPoint Neuro Inc
$11.47+0.37 (+3.33%)PRE
Live · NASDAQ · May 9, Close
AI Insight
What's Moving CLPT Today?
No stock-specific AI insight has been generated for CLPT yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$8.27$30.10
$11.47
Fundamentals
Market Cap$344M
P/E Ratio—
EPS$-0.90
Dividend Yield—
Dividend / Share—
ROE-1.0%
Profit Margin-0.7%
Debt / Equity—
Trading
Volume348K
Avg Volume (10D)—
Shares Outstanding30.0M
CLPT News
20 articles- Tandem Diabetes Care, Inc. (TNDM) Reports Q1 Loss, Tops Revenue EstimatesYahoo Finance·May 7, 2026
- UFP Technologies (UFPT) Tops Q1 Earnings EstimatesYahoo Finance·May 4, 2026
- ClearPoint Neuro to Announce First Quarter 2026 Results May 13, 2026Yahoo Finance·Apr 29, 2026
- ClearPoint Neuro Announces FDA Clearance of the Velocity Alpha(R) MR High Speed Surgical Drill System and First Clinical Use, Further Expanding Our Drug Delivery Ecosystem and Global FootprintYahoo Finance·Apr 22, 2026
- [Latest] Global Surgical Drill Bits Market Size/Share Worth USD 540 Million by 2035 at a 5.5% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)Yahoo Finance·Apr 21, 2026
- ClearPoint Neuro Announces Canadian Approval for its Navigation System Further Expanding Our Drug Delivery Ecosystem and Global FootprintYahoo Finance·Apr 20, 2026
- Why The ClearPoint Neuro (CLPT) Investment Story Is Shifting On Regulatory And Partnership RisksYahoo Finance·Apr 6, 2026
- Why The ClearPoint Neuro (CLPT) Story Is Shifting After New Partner And FDA UpdatesYahoo Finance·Mar 23, 2026
- ClearPoint Neuro Q4 Earnings Call HighlightsMarketbeat·Mar 18, 2026
- ClearPoint Neuro, Inc. Q4 2025 Earnings Call SummaryMoby·Mar 18, 2026
- ClearPoint Neuro (CLPT) Earnings Call TranscriptMotley Fool·Mar 17, 2026
- ClearPoint Neuro, Inc. (CLPT) Reports Q4 Loss, Tops Revenue EstimatesYahoo Finance·Mar 17, 2026
- ClearPoint Neuro Reports Fourth Quarter and Full Year 2025 ResultsYahoo Finance·Mar 17, 2026
- ClearPoint Neuro Inc (CLPT) Q4 2025 Earnings Report Preview: What To ExpectYahoo Finance·Mar 16, 2026
- ClearPoint Neuro (CLPT) Moves 8.1% Higher: Will This Strength Last?Yahoo Finance·Mar 9, 2026
- How The ClearPoint Neuro (CLPT) Investment Story Is Shifting After FDA Feedback And Valuation CutYahoo Finance·Mar 7, 2026
- ClearPoint Neuro to Announce Fourth Quarter and Full Year 2025 Results March 17, 2026Yahoo Finance·Mar 6, 2026
- CLPT Gets EU MDR Certification for ClearPoint Navigation SoftwareYahoo Finance·Jan 27, 2026
- ClearPoint Neuro Announces EU MDR Certification for ClearPoint Navigation Software Version 3.0.2, Expanding Access to the Latest Operating Room Navigation Platform in EuropeYahoo Finance·Jan 22, 2026
- While institutions own 40% of ClearPoint Neuro, Inc. (NASDAQ:CLPT), individual investors are its largest shareholders with 52% ownershipYahoo Finance·Jan 20, 2026
All 20 articles loaded
Price Data
Open$11.37
Previous Close$11.10
Day High$11.49
Day Low$11.07
52 Week High$30.10
52 Week Low$8.27
52-Week Range
$8.27$30.10
$11.47
Fundamentals
Market Cap$344M
P/E Ratio—
EPS$-0.90
Dividend Yield—
Dividend / Share—
ROE-1.0%
Profit Margin-0.7%
Debt / Equity—
Trading
Volume348K
Avg Volume (10D)—
Shares Outstanding30.0M
About ClearPoint Neuro Inc
ClearPoint Neuro, Inc. is a medical device company primarily in the United States. The company is headquartered in Irvine, California.
HEALTHCAREMEDICAL DEVICES
Company Details
Security TypeStock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICMEDICAL DEVICES
CIK—
Composite FIGI—
Share Class FIGI—